- Home
- BDSX vs DHY Comparison
BDSX vs DHY Comparison
Compare BDSX & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- DHY
- Stock Information
- Founded
- BDSX 2005
- DHY 1998
- Country
- BDSX United States
- DHY United States
- Employees
- BDSX N/A
- DHY N/A
- Industry
- BDSX Precision Instruments
- DHY Finance/Investors Services
- Sector
- BDSX Health Care
- DHY Finance
- Exchange
- BDSX Nasdaq
- DHY Nasdaq
- Market Cap
- BDSX 194.9M
- DHY 221.5M
- IPO Year
- BDSX 2020
- DHY N/A
- Fundamental
- Price
- BDSX $1.51
- DHY $2.16
- Analyst Decision
- BDSX Strong Buy
- DHY
- Analyst Count
- BDSX 4
- DHY 0
- Target Price
- BDSX $3.08
- DHY N/A
- AVG Volume (30 Days)
- BDSX 332.5K
- DHY 569.1K
- Earning Date
- BDSX 11-01-2024
- DHY 01-01-0001
- Dividend Yield
- BDSX N/A
- DHY 9.10%
- EPS Growth
- BDSX N/A
- DHY N/A
- EPS
- BDSX N/A
- DHY N/A
- Revenue
- BDSX $65,562,000.00
- DHY N/A
- Revenue This Year
- BDSX $46.97
- DHY N/A
- Revenue Next Year
- BDSX $30.43
- DHY N/A
- P/E Ratio
- BDSX N/A
- DHY N/A
- Revenue Growth
- BDSX 48.92
- DHY N/A
- 52 Week Low
- BDSX $1.11
- DHY $1.77
- 52 Week High
- BDSX $2.21
- DHY $2.08
- Technical
- Relative Strength Index (RSI)
- BDSX 48.94
- DHY 37.02
- Support Level
- BDSX $1.24
- DHY $2.20
- Resistance Level
- BDSX $1.43
- DHY $2.17
- Average True Range (ATR)
- BDSX 0.10
- DHY 0.03
- MACD
- BDSX 0.01
- DHY -0.01
- Stochastic Oscillator
- BDSX 64.44
- DHY 5.00
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company with the objective to seek high current income and capital appreciation as a secondary objective.